2-(4-ピリジニルメチルアミノ)-N-[3-(トリフルオロメチル)フェニル]ベンズアミド

2-(4-ピリジニルメチルアミノ)-N-[3-(トリフルオロメチル)フェニル]ベンズアミド 価格

2-(4-ピリジニルメチルアミノ)-N-[3-(トリフルオロメチル)フェニル]ベンズアミド 化学特性,用途語,生産方法

• 一般的な説明

  A cell-permeable anthranilamide that acts as a potent VEGFR inhibitor (IC₅₀ = 130, 23, and 18 nM against VEGFR-1, -2, and -3, respectively; IC₅₀ = 1.24 nM against VEGF-induced human VEGFR-2 phosphorylation in CHO cells) by targeting the ATP-binding site of VEGFR in its inactive "DFG-out" conformation and effectively suppresses tumor growths (50 to 100 mg/kg; p.o.) via its anti-angiogenesis activity in mice and rats in vivo, while inhibiting c-kit, CSF-1R/c-Fms, PDGFR-β, and c-Abl only at higher concentrations (IC₅₀ = 236, 380, 640, and 2820 nM, respectively). AAL933 and two other VEGFR inhibitors, KRN633 and SU5416, are also shown to inhibit hypoxia-induced HIF-1α expression (by <90% at 30 M) and transcription activation. Unlike KRN633 and SU5416, AAL933 prevents only hypoxia-induced Erk, but not Akt, phosphorylation in HeLa cells.

2-(4-ピリジニルメチルアミノ)-N-[3-(トリフルオロメチル)フェニル]ベンズアミド 生産企業

Global(74)Suppliers

269390-77-4, 2-(4-ピリジニルメチルアミノ)-N-[3-(トリフルオロメチル)フェニル]ベンズアミド キーワード